Track topics on Twitter Track topics that are important to you
An investigational agent originally developed for sarcopenia has shown promise in a phase 2 trial in those with obesity and type 2 diabetes, leading to a loss of body fat as well as weight reduction.
Medscape Medical News
Original Article: Investigational Drug Promising in Obese Patients With DiabetesNEXT ARTICLE
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...